Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group.
Popovic S, Jovanovic D, Mihaljevic B, Andjelkovic N, Marjanovic G, Marisavljevic D, Vlaisavljevic N, Popovic L, Salma S, Agic D, Milosevic R, Smiljanic M, Sretenović S, Djurdjević P, Markovic O, Hajder J, Govedarovic N.
Popovic S, et al. Among authors: popovic l.
J BUON. 2017 Mar-Apr;22(2):487-494.
J BUON. 2017.
PMID: 28534374
Free article.